Sperotto, S., Paolo, G. D., Nichetti, F., Rizzato, M. D., Rosa, A. D., Vitale, G., Bosa, M., Baldan, S., Bolshinsky, M., Galiano, A., Djaballah, S. A., Soldà, C., Buggin, F., Bergamo, F., Lonardi, S., Procaccio, L. (2026). PAXG versus (m)FOLFIRINOX as first-Line therapy for unresectable locally advanced or metastatic pancreatic cancer: A real-world, propensity-weighted analysis.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16401